drugset / Trial / NCT00399685
Drug Interaction - Oral Contraceptive
Non-randomizedParallel-groupOpen-label
Summary
The purpose of this study is to administer a combined oral contraceptive containing ethinyl estradiol and norgestimate with the HIV treatment of efavirenz to healthy females in order to assess if the concentrations of the oral contraceptives change. The safety of this treatment regimen will also be studied.
Timeline
- Start
- 2006-12
- Primary completion
- 2007-08
- Completion
- 2007-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Efavirenz | Other / unclassified | 600 mg | Oral |
| Comparator | Ortho Tri-Cyclen LO | Unknown | — | Oral |
| Comparator | Ortho-Cyclen | Unknown | — | Oral |